Skip to content
healthcare.dev

Mucus Relief DM Maximum Strength

NDC 68016-674, Guaifenesin, Dextromethorphan HBr, tablet, from Chain Drug Consortium, LLC.

Product NDC
68016-674
Status
Listed
Labeler
Chain Drug Consortium, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209692
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68016-674 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROMETHORPHAN HYDROBROMIDE60 mg/1
  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
68016-674-146801606741414 BLISTER PACK in 1 CARTON (68016-674-14) / 1 TABLET in 1 BLISTER PACK
68016-674-286801606742828 BLISTER PACK in 1 CARTON (68016-674-28) / 1 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68016-674 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68016-674 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68016-674. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.